Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Novelion Therapeutics
NVLN

Buy Novelion Therapeutics (NVLN) Stock

NVLN
See NVLN stock price and Buy/Sell Novelion Therapeutics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
NVLN

Novelion Therapeutics (NVLN)

About Novelion Therapeutics (NVLN)

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Ph...Read more
Market Cap
$13.78M
1 Year High
$1.60
Volume
1 Year Low
$0.54
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch NVLN stock

Novelion Therapeutics Stock News

Novelion Therapeutics stock rating

What analysts recommend for NVLN stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
3

Novelion Therapeutics price target

What analysts think NVLN will be worth
Low $0
High $6.50
Current $0
Target $6.50

Novelion Therapeutics earnings

The value each share was expected to gain vs. the value that each share actually gained
0.15
-0.46
-1.07
-1.67
Q4 2018
Q1 2019

Expected EPS
Q1 2019
$0.10
Actual EPS
Q1 2019
-$1.67

Buy Novelion Therapeutics (NVLN) Stock

NVLN
See NVLN stock price and Buy/Sell Novelion Therapeutics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch NVLN stock
  • moedesigner avatar
  • Rhleisure avatar
  • Eggrollz avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.